Search Reports:
  Search
spacer
MORE INFORMATIONarrow
Not sure this is the report that you need? Have questions about the report before purchasing? We're here to help!
HOW TO ORDERarrow
Ordering reports couldn't be easier. Select the license for your needs, click Order Now, and complete our streamlined checkout process. We accept major credit cards, wire/bank transfers, and checks.

MC, Visa, AMEX, Diners, Discovery, JCB
MORE OPTIONSarrow
ABOUT THE PUBLISHERarrow
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including Daily Alerts, monthly regional Insights, and in-depth quarterly Country Forecast Reports.

Iraq Pharmaceuticals & Healthcare Report Q2 2014

Published by Business Monitor International on Apr 7, 2014 - 75 pages
PDF - Download Now with 3 Quarterly Updates format - Download Now
License Options Question

Report Abstract Request Details
The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oil-driven economic expansion, which is dependent on the government's ability to represent and appease the country's factions. Given the government's expansionary fiscal policy, spending on education, health and public services will be elevated over the coming quarters. In particular, Baghdad will seek to modernise healthcare provision, in a view to improve support to its rule. Nevertheless, there are numerous factors hampering market growth. Corruption aside, counterfeit, out-dated and substandard drugs are present in the market, particularly the Kurdistan region. This is a major concern as patients purchase drugs - often at high prices - believing that they are genuine, when a lack of trained healthcare personal, absence of government quality checks and controls, and the powerful influence of illegal factories means that this is not the case.






Copyright © 2014 Fast Market Research, Inc.